Literature DB >> 19108694

Genotypic characterization of CRF01_AE env genes derived from human immunodeficiency virus type 1-infected patients residing in central Thailand.

Piraporn Utachee1, Piyamat Jinnopat, Panasda Isarangkura-Na-Ayuthaya, Udayanga Chandimal de Silva, Shota Nakamura, Uamporn Siripanyaphinyo, Nuanjun Wichukchinda, Kenzo Tokunaga, Teruo Yasunaga, Pathom Sawanpanyalert, Kazuyoshi Ikuta, Wattana Auwanit, Masanori Kameoka.   

Abstract

CRF01_AE is a major subtype of human immunodeficiency virus type 1 (HIV-1) circulating in Southeast Asia, including Thailand. HIV-1 env genes were amplified by polymerase chain reaction from blood samples of HIV-1-infected patients residing in Thailand in 2006, and cloned into the pNL4-3-derived reporter viral construct. Generated envelope protein (Env)-recombinant virus was examined for its infectivity, and then 35 infectious CRF01_AE Env-recombinant viruses were selected. Sequencing analysis revealed that the interclone variation of the deduced amino acid sequences was higher in CRF01_AE env genes isolated in 2006 than in those isolated in the early 1990s, suggesting that env gene variation has been increasing gradually among CRF01_AE viruses prevalent in Thailand. We also examined the characteristics of the deduced amino acid sequences of 35 CRF01_AE env genes. Our results may provide useful information to help in better understanding the genotype of env genes of CRF01_AE viruses currently circulating in Thailand.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19108694     DOI: 10.1089/aid.2008.0232

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  10 in total

1.  Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trial.

Authors:  Gustavo H Kijak; Sodsai Tovanabutra; Supachai Rerks-Ngarm; Sorachai Nitayaphan; Chirapa Eamsila; Prayura Kunasol; Chirasak Khamboonruang; Prasert Thongcharoen; Chawetsan Namwat; Nakorn Premsri; Michael Benenson; Patricia Morgan; Meera Bose; Eric Sanders-Buell; Robert Paris; Merlin L Robb; Deborah L Birx; Mark S De Souza; Francine E McCutchan; Nelson L Michael; Jerome H Kim
Journal:  J Virol       Date:  2013-04-10       Impact factor: 5.103

2.  Characterization of HIV-1 CRF01_AE env Genes Derived from Recently Infected Indonesian Individuals.

Authors:  Maho Sasaki; Tomohiro Kotaki; Siti Qamariyah Khairunisa; Shingo Tachibana; Youdiil Ophinni; Yoshitake Hayashi; Masanori Kameoka
Journal:  AIDS Res Hum Retroviruses       Date:  2019-10-03       Impact factor: 2.205

3.  Genotypic prediction of HIV-1 CRF01-AE tropism.

Authors:  Stéphanie Raymond; Pierre Delobel; Sylvie Rogez; Stéphanie Encinas; Patrick Bruel; Christophe Pasquier; Karine Sandres-Sauné; Bruno Marchou; Patrice Massip; Jacques Izopet
Journal:  J Clin Microbiol       Date:  2012-12-05       Impact factor: 5.948

4.  Two N-linked glycosylation sites in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 regulate viral neutralization susceptibility to the human monoclonal antibody specific for the CD4 binding domain.

Authors:  Piraporn Utachee; Shota Nakamura; Panasda Isarangkura-Na-Ayuthaya; Kenzo Tokunaga; Pathom Sawanpanyalert; Kazuyoshi Ikuta; Wattana Auwanit; Masanori Kameoka
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

5.  Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying env from an RV144 Volunteer to Rhesus Macaques: Coreceptor Switch and Final Recovery of a Pathogenic Virus with Exclusive R5 Tropism.

Authors:  Hanna B Scinto; Sandeep Gupta; Swati Thorat; Muhammad M Mukhtar; Anthony Griffiths; Jennifer Delgado; Elizabeth Plake; Hemant K Vyas; Amanda Strickland; Siddappa N Byrareddy; David C Montefiori; Celia LaBranche; Ranajit Pal; Jim Treece; Sharon Orndorff; Maria Grazia Ferrari; Deborah Weiss; Agnes-Laurence Chenine; Robert McLinden; Nelson Michael; Jerome H Kim; Merlin L Robb; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Ruth M Ruprecht
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

6.  Phylodynamics of HIV-1 from a phase III AIDS vaccine trial in Bangkok, Thailand.

Authors:  Marcos Pérez-Losada; David V Jobes; Faruk Sinangil; Keith A Crandall; Miguel Arenas; David Posada; Phillip W Berman
Journal:  PLoS One       Date:  2011-03-10       Impact factor: 3.240

7.  Molecular evolution of HIV-1 CRF01_AE Env in Thai patients.

Authors:  Samatchaya Boonchawalit; Duangrat Jullaksorn; Jiraporn Uttiyoung; Amara Yowang; Nongkran Krathong; Sununta Chautrakul; Akifumi Yamashita; Kazuyoshi Ikuta; Amornsak Roobsoong; Sangkom Kanitvittaya; Pathom Sawanpanyalert; Masanori Kameoka
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

8.  Impact of amino acid substitutions in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 on viral neutralization susceptibility to broadly neutralizing antibodies specific for the CD4 binding site.

Authors:  Piraporn Utachee; Panasda Isarangkura-na-ayuthaya; Kenzo Tokunaga; Kazuyoshi Ikuta; Naokazu Takeda; Masanori Kameoka
Journal:  Retrovirology       Date:  2014-04-23       Impact factor: 4.602

9.  CRF01_AE-specific neutralizing activity observed in plasma derived from HIV-1-infected Thai patients residing in northern Thailand: comparison of neutralizing breadth and potency between plasma derived from rapid and slow progressors.

Authors:  Sompong Sapsutthipas; Naho Tsuchiya; Panita Pathipavanich; Koya Ariyoshi; Pathom Sawanpanyalert; Naokazu Takeda; Panasda Isarangkura-na-ayuthaya; Masanori Kameoka
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

10.  High prevalence of HIV-1 CRF01_AE viruses among female commercial sex workers residing in Surabaya, Indonesia.

Authors:  Tomohiro Kotaki; Siti Qamariyah Khairunisa; Septhia Dwi Sukartiningrum; M Vitanata Arfijanto; Takako Utsumi; Irine Normalina; Retno Handajani; Prihartini Widiyanti; Musofa Rusli; Retno Pudji Rahayu; Maria Inge Lusida; Yoshitake Hayashi; Masanori Kameoka
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.